Alexion Pharmaceuticals Inc. (ALXN) Share Price ($):99.20 Price Change: 0.30 (0.30%)

Expand Company Information
Volume 1,491,509 Avg Volume 1,878,460
Day's Low $97.46 Day's High $99.70
52-wk Low $81.28 52-wk High $119.54
Previous Close $98.90 Open Price $98.05
Dividend $NA Yield NA%
Market Cap 19,364,700,000 P/E (Forward) 34.48
Chart for ALXN
Exchange: NASDAQ Industry: Pharmaceuticals & Biotechnology Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes: What's This?
    Find a Broker »
    Choose Option: 

    Income Statement (Non-Cumulative)

    Print Current View
      Fiscal Q4
    Ending 12/12    		 Fiscal Q3
    Ending 09/12    		 Fiscal Q2
    Ending 06/12    		 Fiscal Q1
    Ending 03/12    		 Fiscal Q4
    Ending 12/11
    Sales/Revenue
    		 316,542 294,136 274,719 244,733 228,726
    Cost of Goods Sold (COGS) incl. D&A
    		 35,123 86,667 31,717 28,372 28,902
    COGS excluding D&A
    		 28,849 80,473 26,173 22,497 24,488
    Depreciation & Amortization Expense
    		 6,274 6,194 5,544 5,875 4,414
    Gross Income
    		 281,419 207,469 243,002 216,361 199,824
    SG&A Expense
    		 174,162 144,237 154,490 132,650 120,965
    Research & Development
    		 61,538 54,280 59,635 45,408 34,398
    Other SG&A
    		 112,624 89,957 94,855 87,242 86,567
    Other Operating Expense
    		 0 0 0 0 0
    Unusual Expense
    		 -3,350 30,737 8,955 13,782 3,489
    Non Operating Income/Expense
    		 -3,122 109,808 3,962 -106 -1,109
    Equity in Affiliates (Pretax)
    		 NA 0 0 0 0
    Interest Expense
    		 1,182 1,855 2,079 2,287 183
    Gross Interest Expense
    		 1,182 1,855 2,079 2,287 183
    Pretax Income
    		 107,269 140,765 81,722 67,809 74,078
    Income Tax
    		 26,298 48,586 45,464 22,396 25,908
    Equity in Affiliates
    		 0 0 0 0 0
    Consolidated Net Income
    		 80,971 92,179 36,258 45,413 48,170
    Minority Interest Expense
    		 0 0 0 0 0
    Net Income
    		 80,971 92,179 36,258 45,413 48,170
    Extraordinaries & Discontinued Operations
    		 0 0 0 0 0
    Extra Items & Gain/Loss Sale Of Assets
    		 0 0 0 0 0
    Cumulative Effect - Accounting Chg
    		 0 0 0 0 0
    Discontinued Operations
    		 0 0 0 NA 0
    Net Income After Extraordinaries
    		 80,971 92,179 36,258 45,413 48,170
    Preferred Dividends
    		 0 0 0 0 0
    Net Income available to Common
    		 80,971 92,179 36,258 45,413 48,170
    Operational EPS
    		 0.40 0.57 0.22 0.28 0.26
    EPS (basic)
    		 0.43 0.48 0.19 0.24 0.26
    EBITDA
    		 113,531 69,426 94,056 89,586 83,273
    Depreciation & Amortization Expense
    		 6,274 6,194 5,544 5,875 4,414
    Common Shares Outstanding
    		 NA 201,142 197,051 194,560 191,806
    Basic Shares Outstanding
    		 190,461 193,353 188,575 185,682 183,220
    Diluted Shares Outstanding
    		 198,501 201,142 197,051 194,560 191,806
    Diluted EPS after Extraordinary Items
    		 0.41 0.46 0.18 0.23 0.25
    Discont. Operations Per Share
    		 NA 0 0 0 0
    Continued operations EPS
    		 NA 0.48 0.19 0.24 0.25
    *Figures in thousands of U.S. Dollars except shares outstanding.
    • Print Snapshot
    • Stock Compare
    • Receive Stock Alerts
    • Receive News Alerts
    • Glossary
    • RSS
    • Price Check Calculator
    • Annual Reports
    tools

    Stock Screener

    Portfolio Tracker

    See More Tools